Navigation Links
Sepsis Therapy in Preemies Fails to Boost Survival
Date:1/16/2009

Study suggests future treatments should focus on wider view of antibacterial defenses

FRIDAY, Jan. 16 (HealthDay News) -- Boosting the immune systems of premature babies with blood cell growth factor fails to prevent sepsis or improve survival rates, a new study shows.

Premature babies, especially those with lower than normal birth weight, tend to be prone to infections from low white blood cell counts. Blood growth factors, such as granulocyte-macrophage colony stimulating factor (GM-CSF), increase white blood cell counts and are often used in cancer patients to counter immune suppression caused by chemotherapy.

The London-based study, published in the current issue of The Lancet, found giving GM-CSF to premature babies with low birth weight did increase their white counts but, when compared with preterms who did not receive the treatment, they did not have lower rates of infection or better survival rates.

"We believe that, before embarking on future single-agent clinical trials, we should consider if this is too simplistic an approach to sepsis prevention in the preterm infant, whose immune system appears compromised in many different ways. ... Successful future stratagems will need a wider view of their antibacterial defenses," wrote the authors, lead by Robert Carr of Guy's and St Thomas Hospital NHS Trust in London.

More information

The U.S. National Library of Medicine has more about sepsis.



-- Kevin McKeever



SOURCE: The Lancet, news release, Jan. 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
2. Educational Drive Cut Death Rate From Sepsis
3. Ashwell receptor reduces mortality during sepsis
4. Customized treatments for sepsis lower treatment time and reduce length of ICU stays
5. Research May Yield New Weapons Against Sepsis
6. Blacks More Likely to Die of Severe Sepsis
7. Scientists Probe Sepsis Deadly Secrets
8. Estonian Cancer Patients Have Access to More Conformal Radiotherapy Treatments for First Time with Unveiling of Advanced Varian Treatment Machine
9. Hispanics Respond Poorly to Standard Hepatitis C Therapy
10. UNC study supports role of circadian clock in response to chemotherapy
11. North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sepsis Therapy in Preemies Fails to Boost Survival 
(Date:5/25/2016)... ... 25, 2016 , ... Afrimesure specializes in providing clients with ... food and HVAC facilities. Their knowledgeable staff also takes care of the installation, ... Afrimesure offers a variety of MadgeTech systems available for sterilization and temperature monitoring, ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... The University ... Nursing and Health Professions. She will lead a team of more than 100 full-time ... will begin her role as dean in late August. , Baker comes to USF ...
(Date:5/25/2016)... ... May 25, 2016 , ... For more than fifty years, we've suffered whiplash as each ... diets to conform to the latest nutritional advice – advice that was supposed to keep ... than 2 in 3 American adults are considered to be overweight and more than 1 ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... "FCPX LUT ... quality of your footage," said Christina Austin - CEO of Pixel Film Studios. ... can quickly and easily add stylish color grades to their footage. A LUT is ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... LONDON , May 24, 2016   ... primary endpoints demonstrating non-inferiority in overall bowel cleansing and superiority ... c leansing of ... http://photos.prnewswire.com/prnh/20130829/633895-a ) , Norgine B.V. today announced ... (1 litre PEG and ascorbate bowel preparation) versus standard 2 litre ...
(Date:5/24/2016)... LAWRENCEVILLE, N.J. , May 24, 2016 /PRNewswire/ ... an oncology drug development company, today provided an ... Ib dose escalating clinical trial combining GEN-1, the ... for the treatment of newly-diagnosed patients with advanced ... by interval debulking surgery.  GEN-1 is an IL-12 ...
Breaking Medicine Technology: